National Collaborative Innovation Center for Biotherapy
生物治疗协同创新中心
China
1 October 2019 - 30 September 2020
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for National Collaborative Innovation Center for Biotherapy published between 1 October 2019 - 30 September 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Research collaboration: National Collaborative Innovation Center for Biotherapy is a research collaboration whose article contributions are accrued to its participating partner institutions.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
7 | 1.85 |
Outputs by subject (Share)
Subject | Count | Share | |
---|---|---|---|
Life Sciences | 6 | 1.79 | |
Chemistry | 1 | 0.06 |
Top articles by Altmetric score in current window
Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer
Nature Medicine
2020-04-27
PHD1 controls muscle mTORC1 in a hydroxylation-independent manner by stabilizing leucyl tRNA synthetase
Nature Communications
2020-01-10
Cryo-EM structures of HKU2 and SADS-CoV spike glycoproteins provide insights into coronavirus evolution
Nature Communications
2020-06-17
Transcriptomic and open chromatin atlas of high-resolution anatomical regions in the rhesus macaque brain
Nature Communications
2020-01-24
1 October 2019 - 30 September 2020
International vs. domestic collaboration by Share
- 74.96% Domestic
- 25.04% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by Share (21 total)
- National Collaborative Innovation Center for Biotherapy, China
- Domestic institution
-
Chinese Academy of Sciences (CAS), China
(1.27)
-
Beijing Advanced Innovation Center for Structural Biology (ICSB-BJ), China
(0.67)
-
Geneplus-Beijing Institute, China
(0.64)
-
Chengdu MedGenCell Co., Ltd., China
(0.59)
-
Fudan University, China
(0.59)
-
Southwest Medical University (SWMU), China
(0.58)
-
ZenRhyme Consulting Service, Ltd., China
(0.57)
-
Berry Oncology Co., Ltd., China
(0.54)
-
The Chinese University of Hong Kong (CUHK), China
(0.54)
-
Shanghai Jiao Tong University (SJTU), China
(0.53)
Top 10 international collaborators by Share (16 total)
- National Collaborative Innovation Center for Biotherapy, China
- Foreign institution
-
University of Pennsylvania (Penn), United States of America (USA)
(0.82)
-
Penn Medicine, United States of America (USA)
(0.76)
-
Albert Einstein College of Medicine (Einstein), United States of America (USA)
(0.53)
-
NYC Health and Hospitals, United States of America (USA)
(0.53)
-
Swiss Federal Institute of Technology Zurich (ETH Zurich), Switzerland
(0.38)
-
Children's National Health System, United States of America (USA)
(0.21)
-
University of Birmingham (UB), United Kingdom (UK)
(0.13)
-
University of Oulu, Finland
(0.09)
-
Seoul National University (SNU), South Korea
(0.09)
-
MRC/Arthritis Research UK Centre for Musculoskeletal Ageing Research (CMAR), United Kingdom (UK)
(0.09)
Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.
Participating institutions
National Collaborative Innovation Center for Biotherapy is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.